Treatment of Intractable Neurogenic Cough with Cricopharyngeal Myotomy by Lee Durstenfeld, BS, Anne et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Otolaryngology - Head and Neck
Surgery Faculty, Presentations and Grand Rounds
Department of Otolaryngology - Head and Neck
Surgery
4-10-2013
Treatment of Intractable Neurogenic Cough with
Cricopharyngeal Myotomy
Anne Lee Durstenfeld, BS
Thomas Jefferson University, anne.lee@jefferson.edu
Joseph Spiegel, MD
Thomas Jefferson University, Joseph.Spiegel@jefferson.edu
Mauritis Boon, MD
Thomas Jefferson University, Maurits.Boon@jefferson.edu
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/otograndrounds
Part of the Otolaryngology Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Otolaryngology - Head and Neck Surgery Faculty, Presentations and Grand Rounds by an authorized administrator of the Jefferson
Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Lee Durstenfeld, BS, Anne; Spiegel, MD, Joseph; and Boon, MD, Mauritis, "Treatment of Intractable
Neurogenic Cough with Cricopharyngeal Myotomy" (2013). Department of Otolaryngology - Head
and Neck Surgery Faculty, Presentations and Grand Rounds. Presentation 14.
http://jdc.jefferson.edu/otograndrounds/14
Poster Design & Printing by Genigraphics® - 800.790.4001  
Objectives: Neuropathic cough that 
is incompletely responsive to medical 
therapy may be due to 
cricopharyngeal hypertonicity. The 
objective was to describe the utility of 
cricopharyngeal myotomy in 
alleviating symptoms of intractable 
neuropathic cough.  
Study Design: Retrospective review. 
Methods: A retrospective chart 
review was performed for three 
patients who underwent 
cricopharyngeal myotomy for 
intractable cough. Trigger 
phenomena, previous evaluation and 
treatment, and outcomes after 
surgery, namely patient perception of 
improvement and medication use 
after surgery, were assessed and 
documented.  
Results: After cricopharyngeal 
myotomy, all three patients noted 
symptomatic improvement and were 
weaned off medication. Continued 
improvement was noted at follow up, 
with a mean length of 22 months 
(range: 7-36 months). 
Conclusions: Cricopharyngeal 
myotomy may be an alternative 
treatment for chronic cough in 
patients for whom workup is negative 
and medical management, dilation, 
and botulinum toxin have failed to 
provide long-term relief.  
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 In the majority of patients, systematic evaluation 
and optimal therapy will lead to successful resolution of 
chronic cough.7 However, in patients for whom thorough 
work-up and empirical treatment have not produced a 
solution, several models have been described. These 
include irritable larynx syndrome, sensory laryngeal 
neuropathic cough, and post-viral vagal neuropathy, 
which fall under the newly coined umbrella term of 
chronic cough hypersensitivity syndrome.8 Just as other 
neuropathies may manifest as paralysis or 
hypersensitivity to stimuli, vagal neuropathy may 
present as dysphonia, dysphagia, paresis, pain, 
laryngospasm, or cough. Neuropathy of motor branches 
may lead to symptoms of dysphagia and dysphonia 
while that of sensory branches produces pain and 
decreased cough threshold.  
 Bastian et al proposed criteria for a sensory 
neuropathic model of intractable persistent cough, 
including irritable cervical and laryngeal sensations, 
severe attacks of non-productive cough that may be 
triggered or occur spontaneously, and exclusion criteria 
based on psychogenic factors such as secondary gain 
and abrupt onset or resolution. Based on this model, 
75% of their patients were treated successfully with 
amitriptyline.1 By treating paroxysmal chronic cough as 
a neuropathic pain disorder, Lee and Woo were able to 
achieve symptomatic relief in 68% of patients using 
gabapentin, while Van de Kerkhove et al used 
gabapentin to decrease cough severity in 20 of 35 
patients.3,4 A randomized controlled trial by Ryan et al 
showed clinically and statistically significant 
improvement with gabapentin in 84% of patients 
compared to 40% on placebo; however, cough returned 
after cessation of therapy.5 Chu et al attributed the 
decreased threshold for cough stimulation and 
increased laryngeal tone to hyperexcitable sensory and 
motor pathways and aimed to inhibit neurogenic 
inflammation and hypertonicity using botulinum toxin 
injection of the thyroarytenoid muscles. They reported 
complete resolution of cough in a case series of 4 
patients.6  
 In this paper, we report on the use of open 
cricopharyngeal myotomy to treat chronic cough. The 
rationale behind targeting the cricopharyngeus came 
from the observation that these patients identified a 
trigger at the approximate level of the cricopharyngeus 
and had elevated UES resting pressures on manometry. 
Additionally, each had previously obtained improvement 
in cough from dilation and/or botulinum toxin injection of 
the UES, which can be considered alternatives to 
cricopharyngeal myotomy.  However, relief was self-
limited and therefore cricopharyngeal myotomy was 
offered as a possible permanent solution. Notably, all 
patients experienced marked improvement. Our 
experience with cricopharyngeal myotomy suggests that 
successful treatment of neuropathic cough can be 
achieved by relieving pharyngeal hypertonicity in select 
patients. The recent literature on endoscopic 
cricopharyngeal myotomy suggests that the technique 
may also be a viable consideration for this population. 
However, this would require further study. 
 A retrospective chart review was 
performed for three patients who 
underwent cricopharyngeal myotomy for 
intractable cough. Trigger phenomena, 
previous evaluation and treatment, and 
outcomes from their surgery were 
assessed and documented. Outcome 
measures included use of medication after 
surgery and patient perception of 
improvement. 
 In conclusion, cricopharyngeal myotomy may be 
an alternative treatment for chronic cough in patients for 
whom workup is negative and medical management, 
dilation, and botulinum toxin have failed to provide long-
term relief.  However, further study is warranted in this 
patient population to support this assertion.   
 
 Chronic cough is a challenging 
diagnostic and therapeutic entity due to its 
multiple etiologies. For patients whose 
cough does not improve with appropriate 
treatment for common causes, a 
neuropathic etiology can be considered. 
This characteristic symptom complex is 
typically longstanding, has trigger 
phenomena, is preceded by tickle 
sensations in the throat, and produces 
paroxysms of unproductive cough.1 Bastian 
et al, who proposed these diagnostic 
criteria, posit that vagal neuropathy 
manifested as laryngeal hypertonicity or 
hypersensitivity may be the cause. Some 
success has been reported regarding 
management with anticonvulsants and 
antidepressants as well as botulinum toxin 
injections.1-6 However, some cases may be 
refractory to such treatments. In this report, 
we describe 3 patients diagnosed with 
neuropathic cough who had incomplete 
response to medical therapy and were 
identified as having a trigger at the 
cricopharyngeus. All 3 patients underwent 
cricopharyngeal myotomy (CPM) with 
successful resolution of cough. 
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	 Case	1	 Case	2	 Case	3	
Duration	of	cough	 15	years	 21	years	 22	years	
PMH	 Sinusitis.		 Sinusitis,	GERD	s/p	
fundoplication,	
laryngospasm.		
Sinusitis	s/p	sinus	
surgery,	GERD,	
asthma,	allergies,	
laryngospasm.		
Smoking	Hx	 10	PY	 10	PY	 Never	smoked	
Manometry	 Increased	UES,	
increased	LES	
resting	pressures	
Increased	UES,	
decreased	LES	
resting	pressures	
Increased	UES,	
decreased	LES	
resting	pressures	
pH	measurement	 No	evidence	of	
GERD	
-	 No	evidence	of	
GERD	
Reflux	
medication	
Failed	Protonix	 Failed	Protonix	 Failed	Prilosec	
Allergy	
medication	
Failed	Zyrtec	 Failed	Advair,	
Singulair,	Clarinex	
Failed	Astelin,	
Claritin,	Tussionex	
Neuropathic	pain	
medications	
Failed	
Amitriptyline,	
nortriptyline,	
Lyrica	
Failed	
nortriptyline,	
gabapentin,	and	
Lyrica	(ADE)	
Failed	
nortriptyline	
(ADE),	Lyrica,	
maintained	on	
amitriptyline	
Dilation	 Once		 Once		 Once	
Botulinum	toxin	 3	times	 Once	 -	
Surgery		 2009	 2010	 2012	
Meds	after	
myotomy	
None	 None	 P.r.n.	use	of	
amitriptyline	
	
Figure 1. The cricopharyngeus muscle and surrounding structures.  
Image from Kelly JH, Management of UES disorders10 
RESULTS 
 Table 1 shows the characteristics of 
the three cases. All were women aged 61-
62 who had suffered from unpredictable 
paroxysms of non-productive coughing for 
15-22 years. Each had also been found to 
have an elevated upper esophageal 
sphincter pressure on manometry (mean: 
184 mmHg, range: 125-219mmHg). None 
had obtained lasting relief from cough after 
trials of anti-allergy, anti-reflux, and more 
traditional therapies. Incomplete or 
temporary relief was experienced from 
neuropathic medications and esophageal 
dilation. Two had experienced temporary 
improvement for 6 months after botulinum 
toxin injection into the cricopharyngeus.  
 Subsequent cricopharyngeal myotomy 
was performed in all patients. All noted 
symptomatic improvement and were 
weaned off medication. Continued 
improvement was noted at follow up, with a 
mean length of 22 months (range: 7-36 
months). 
Table 1. Characteristics of patients. 
